The daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the approval of Novo Nordisks Wegovy pill in December
The dispute comes as regulators around the world face growing questions over the sale of compounded versions of popular weight-loss medicines
Weight & metabolic improvement GLP-1 medications (semaglutide or tirzepatide) produce clinically meaningful weight loss while also improving blood pressure, cholesterol, metabolic inflammation, and glycemic control
GLP-1 receptors are present throughout the body, including in the developing pancreas and gastrointestinal system
However, semaglutide is usually intended as part of a long-term weight management plan rather than a short-term solution
When travelling, invest in a medical-grade cooling case or insulated travel pouch specifically designed for injectable medications